Aethlon Medical, Inc. (AEMD)
USD 0.35
(1.59%)
USD 0.35
(1.59%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 940.31 Thousand USD | -22.23% |
| 2023 | 1.2 Million USD | 65.75% |
| 2022 | 729.41 Thousand USD | 1614.52% |
| 2021 | 42.54 Thousand USD | -69.85% |
| 2020 | 141.09 Thousand USD | -85.34% |
| 2019 | 962.3 Thousand USD | 14.4% |
| 2018 | 841.15 Thousand USD | 62.01% |
| 2017 | 519.2 Thousand USD | -1.63% |
| 2016 | 527.78 Thousand USD | 240.0% |
| 2015 | 155.22 Thousand USD | -93.87% |
| 2014 | 2.53 Million USD | -5.76% |
| 2013 | 2.68 Million USD | -26.54% |
| 2012 | 3.66 Million USD | 54.32% |
| 2011 | 2.37 Million USD | 23.41% |
| 2010 | 1.92 Million USD | -18.98% |
| 2009 | 2.37 Million USD | 201.76% |
| 2008 | 786.14 Thousand USD | 42.29% |
| 2007 | 552.5 Thousand USD | -17.52% |
| 2006 | 669.86 Thousand USD | 36.07% |
| 2005 | 492.3 Thousand USD | -27.07% |
| 2004 | 675 Thousand USD | -36.47% |
| 2003 | 1.06 Million USD | 13.33% |
| 2002 | 937.5 Thousand USD | -45.06% |
| 2001 | 1.7 Million USD | 223.96% |
| 2000 | 526.7 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.07 Million USD | -5.79% |
| 2024 Q4 | 940.31 Thousand USD | -6.89% |
| 2024 Q3 | 1 Million USD | -6.33% |
| 2024 FY | 940.31 Thousand USD | -22.23% |
| 2024 Q1 | 1.14 Million USD | -5.34% |
| 2023 Q2 | 1.32 Million USD | 88.15% |
| 2023 Q3 | 1.27 Million USD | -3.86% |
| 2023 FY | 1.2 Million USD | 65.75% |
| 2023 Q1 | 704.05 Thousand USD | -3.48% |
| 2023 Q4 | 1.2 Million USD | -5.07% |
| 2022 Q2 | - USD | -100.0% |
| 2022 Q1 | 16.83 Thousand USD | -60.43% |
| 2022 FY | 729.41 Thousand USD | 1614.52% |
| 2022 Q4 | 729.41 Thousand USD | 114.05% |
| 2022 Q3 | 340.76 Thousand USD | 0.0% |
| 2021 Q2 | 92.6 Thousand USD | -21.03% |
| 2021 Q3 | 67.69 Thousand USD | -26.89% |
| 2021 Q4 | 42.54 Thousand USD | -37.16% |
| 2021 FY | 42.54 Thousand USD | -69.85% |
| 2021 Q1 | 117.26 Thousand USD | -16.89% |
| 2020 Q3 | 164.4 Thousand USD | -12.31% |
| 2020 Q4 | 141.09 Thousand USD | -14.18% |
| 2020 FY | 141.09 Thousand USD | -85.34% |
| 2020 Q1 | 1.1 Million USD | 14.61% |
| 2020 Q2 | 187.48 Thousand USD | -83.0% |
| 2019 FY | 962.3 Thousand USD | 14.4% |
| 2019 Q4 | 962.3 Thousand USD | 3.25% |
| 2019 Q1 | 871.44 Thousand USD | 3.6% |
| 2019 Q2 | 901.72 Thousand USD | 3.48% |
| 2019 Q3 | 932.01 Thousand USD | 3.36% |
| 2018 Q2 | 780.57 Thousand USD | -25.72% |
| 2018 Q4 | 841.15 Thousand USD | 3.74% |
| 2018 FY | 841.15 Thousand USD | 62.01% |
| 2018 Q1 | 1.05 Million USD | 102.41% |
| 2018 Q3 | 810.86 Thousand USD | 3.88% |
| 2017 Q2 | 605.81 Thousand USD | -1.78% |
| 2017 Q4 | 519.2 Thousand USD | 25.29% |
| 2017 FY | 519.2 Thousand USD | -1.63% |
| 2017 Q1 | 616.81 Thousand USD | 16.87% |
| 2017 Q3 | 414.39 Thousand USD | -31.6% |
| 2016 Q4 | 527.78 Thousand USD | 21.43% |
| 2016 FY | 527.78 Thousand USD | 240.0% |
| 2016 Q1 | 248.36 Thousand USD | 60.0% |
| 2016 Q2 | 341.5 Thousand USD | 37.5% |
| 2016 Q3 | 434.64 Thousand USD | 27.27% |
| 2015 Q3 | 286.75 Thousand USD | -82.77% |
| 2015 Q1 | 1.87 Million USD | -26.04% |
| 2015 FY | 155.22 Thousand USD | -93.87% |
| 2015 Q4 | 155.22 Thousand USD | -45.87% |
| 2015 Q2 | 1.66 Million USD | -11.21% |
| 2014 Q2 | 2.83 Million USD | 13.58% |
| 2014 Q1 | 2.49 Million USD | -7.2% |
| 2014 Q4 | 2.53 Million USD | -3.83% |
| 2014 FY | 2.53 Million USD | -5.76% |
| 2014 Q3 | 2.63 Million USD | -7.04% |
| 2013 Q3 | 2.76 Million USD | -2.79% |
| 2013 Q2 | 2.84 Million USD | -15.64% |
| 2013 Q1 | 3.37 Million USD | -7.89% |
| 2013 FY | 2.68 Million USD | -26.54% |
| 2013 Q4 | 2.68 Million USD | -2.74% |
| 2012 FY | 3.66 Million USD | 54.32% |
| 2012 Q1 | 2.54 Million USD | 7.36% |
| 2012 Q4 | 3.66 Million USD | 20.1% |
| 2012 Q2 | 2.92 Million USD | 15.06% |
| 2012 Q3 | 3.04 Million USD | 4.02% |
| 2011 Q1 | 2.06 Million USD | 7.31% |
| 2011 Q4 | 2.37 Million USD | 15.78% |
| 2011 Q3 | 2.04 Million USD | -2.16% |
| 2011 FY | 2.37 Million USD | 23.41% |
| 2011 Q2 | 2.09 Million USD | 1.51% |
| 2010 Q1 | 1.97 Million USD | -16.76% |
| 2010 FY | 1.92 Million USD | -18.98% |
| 2010 Q4 | 1.92 Million USD | 10.74% |
| 2010 Q3 | 1.73 Million USD | -4.99% |
| 2010 Q2 | 1.82 Million USD | -7.49% |
| 2009 Q4 | 2.37 Million USD | -14.22% |
| 2009 Q2 | 1.93 Million USD | 58.77% |
| 2009 FY | 2.37 Million USD | 201.76% |
| 2009 Q3 | 2.76 Million USD | 43.2% |
| 2009 Q1 | 1.21 Million USD | 54.72% |
| 2008 Q2 | 582.26 Thousand USD | 5.39% |
| 2008 Q4 | 786.14 Thousand USD | -40.36% |
| 2008 Q3 | 1.31 Million USD | 126.4% |
| 2008 FY | 786.14 Thousand USD | 42.29% |
| 2008 Q1 | 552.5 Thousand USD | 0.0% |
| 2007 Q1 | 709.84 Thousand USD | 5.97% |
| 2007 Q4 | 552.5 Thousand USD | -29.3% |
| 2007 Q3 | 781.51 Thousand USD | 3.67% |
| 2007 Q2 | 753.87 Thousand USD | 6.2% |
| 2007 FY | 552.5 Thousand USD | -17.52% |
| 2006 FY | 669.86 Thousand USD | 36.07% |
| 2006 Q1 | 589.93 Thousand USD | 19.83% |
| 2006 Q4 | 669.86 Thousand USD | 20.16% |
| 2006 Q2 | 671.54 Thousand USD | 13.83% |
| 2006 Q3 | 557.5 Thousand USD | -16.98% |
| 2005 Q3 | 471.3 Thousand USD | -1.3% |
| 2005 Q1 | 612.5 Thousand USD | -9.26% |
| 2005 FY | 492.3 Thousand USD | -27.07% |
| 2005 Q4 | 492.3 Thousand USD | 4.46% |
| 2005 Q2 | 477.5 Thousand USD | -22.04% |
| 2004 Q2 | 1.05 Million USD | 0.0% |
| 2004 FY | 675 Thousand USD | -36.47% |
| 2004 Q3 | 952.5 Thousand USD | -9.5% |
| 2004 Q4 | 675 Thousand USD | -29.13% |
| 2004 Q1 | 1.05 Million USD | -0.94% |
| 2003 Q3 | 1.16 Million USD | 6.86% |
| 2003 Q4 | 1.06 Million USD | -8.99% |
| 2003 Q2 | 1.09 Million USD | 19.07% |
| 2003 Q1 | 917.5 Thousand USD | -2.13% |
| 2003 FY | 1.06 Million USD | 13.33% |
| 2002 Q3 | 1.85 Million USD | 3.81% |
| 2002 Q1 | 1.74 Million USD | 2.56% |
| 2002 Q2 | 1.78 Million USD | 2.01% |
| 2002 FY | 937.5 Thousand USD | -45.06% |
| 2002 Q4 | 937.5 Thousand USD | -49.41% |
| 2001 FY | 1.7 Million USD | 223.96% |
| 2001 Q3 | 1.44 Million USD | 38.33% |
| 2001 Q4 | 1.7 Million USD | 18.22% |
| 2001 Q1 | 750.88 Thousand USD | 42.56% |
| 2001 Q2 | 1.04 Million USD | 38.96% |
| 2000 FY | 526.7 Thousand USD | 0.0% |
| 2000 Q1 | 60 Thousand USD | 0.0% |
| 2000 Q2 | 212.5 Thousand USD | 254.17% |
| 2000 Q4 | 526.7 Thousand USD | -8.32% |
| 2000 Q3 | 574.5 Thousand USD | 170.35% |
| 1999 FY | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PetVivo Holdings, Inc. | 1.36 Million USD | 31.114% |
| Talis Biomedical Corporation | 19.66 Million USD | 95.219% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -1549.677% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 97.602% |
| Bioventus Inc. | 409.47 Million USD | 99.77% |
| Cerus Corporation | 95.99 Million USD | 99.02% |
| CVRx, Inc. | 30.61 Million USD | 96.928% |
| electroCore, Inc. | 626 Thousand USD | -50.21% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | 52.902% |
| OrthoPediatrics Corp. | 23.76 Million USD | 96.042% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 93.836% |
| Spectral AI, Inc. | 1.28 Million USD | 27.051% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -91.125% |
| BrainsWay Ltd. | 471 Thousand USD | -99.642% |
| Envoy Medical, Inc. | 404 Thousand USD | -132.751% |
| MaxCyte, Inc. | 18.74 Million USD | 94.983% |
| NanoVibronix, Inc. | 5000.00 USD | -18706.32% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 88.8% |
| Nexalin Technology, Inc. | 4463.00 USD | -20969.146% |
| Orthofix Medical Inc. | 134.19 Million USD | 99.299% |
| Inogen, Inc. | 21.92 Million USD | 95.711% |
| IceCure Medical Ltd | 599 Thousand USD | -56.981% |
| PAVmed Inc | 48.72 Million USD | 98.07% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 69.381% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 87.2% |
| RxSight, Inc. | 3.01 Million USD | 68.781% |
| Sight Sciences, Inc. | 35.41 Million USD | 97.345% |
| SI-BONE, Inc. | 38.99 Million USD | 97.588% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -409.933% |
| TELA Bio, Inc. | 42.78 Million USD | 97.802% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | 41.046% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 98.662% |
| Venus Concept Inc. | 79.69 Million USD | 98.82% |
| Acutus Medical, Inc. | 38.47 Million USD | 97.556% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | 52.866% |
| LivaNova PLC | 640.4 Million USD | 99.853% |
| 908 Devices Inc. | 5.94 Million USD | 84.183% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.826% |
| Nemaura Medical Inc. | 20.03 Million USD | 95.305% |
| NeuroPace, Inc. | 72.39 Million USD | 98.701% |
| LENSAR, Inc. | 2.3 Million USD | 59.276% |
| Apyx Medical Corporation | 38.5 Million USD | 97.558% |
| Cutera, Inc. | 431.91 Million USD | 99.782% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 93.985% |
| BioSig Technologies, Inc. | 452 Thousand USD | -108.035% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 96.762% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 93.255% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.944% |
| Axonics, Inc. | 27.61 Million USD | 96.595% |
| Outset Medical, Inc. | 136.18 Million USD | 99.31% |
| IRIDEX Corporation | 2.74 Million USD | 65.757% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 98.813% |
| IRadimed Corporation | 2.04 Million USD | 53.975% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -154.828% |
| INVO Bioscience, Inc. | 8.68 Million USD | 89.171% |
| Telesis Bio, Inc. | 34.38 Million USD | 97.265% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 90.845% |
| Varex Imaging Corporation | 469.5 Million USD | 99.8% |
| Quipt Home Medical Corp. | 98.94 Million USD | 99.05% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 59.952% |
| Pulmonx Corporation | 41.42 Million USD | 97.73% |
| Dynatronics Corporation | 6.68 Million USD | 85.94% |
| Modular Medical, Inc. | 1.19 Million USD | 20.982% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -258.899% |
| Semler Scientific, Inc. | 70 Thousand USD | -1243.309% |
| InMode Ltd. | 9.01 Million USD | 89.572% |
| Bruker Corporation | 1.37 Billion USD | 99.932% |
| Cytosorbents Corporation | 18.31 Million USD | 94.865% |
| DexCom, Inc. | 2.59 Billion USD | 99.964% |
| Align Technology, Inc. | 96.96 Million USD | 99.03% |
| Viveve Medical, Inc. | 5.34 Million USD | 82.421% |
| ZimVie Inc. | 521.92 Million USD | 99.82% |
| Movano Inc. | 252 Thousand USD | -273.141% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 97.166% |
| Nexalin Technology, Inc. | 4463.00 USD | -20969.146% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 52.902% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.774% |
| Profound Medical Corp. | 7.9 Million USD | 88.098% |
| Insulet Corporation | 1.44 Billion USD | 99.935% |
| enVVeno Medical Corporation | 1.4 Million USD | 32.93% |
| Surmodics, Inc. | 29.4 Million USD | 96.802% |
| iCAD, Inc. | 461 Thousand USD | -103.973% |
| Nuwellis, Inc. | 981 Thousand USD | 4.147% |
| Biotricity, Inc. | 23.87 Million USD | 96.062% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 99.276% |
| InspireMD, Inc. | 1.59 Million USD | 41.046% |
| PAVmed Inc. | 48.72 Million USD | 98.07% |
| BIOLASE, Inc. | 17.91 Million USD | 94.75% |
| Beyond Air, Inc. | 17.83 Million USD | 94.728% |
| FONAR Corporation | 41.67 Million USD | 97.744% |
| AxoGen, Inc. | 69.29 Million USD | 98.643% |
| Vivani Medical, Inc. | 20.69 Million USD | 95.457% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 98.133% |
| Inari Medical, Inc. | 32.04 Million USD | 97.066% |
| UFP Technologies, Inc. | 46.03 Million USD | 97.957% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | 9.266% |
| Tenon Medical, Inc. | 1.17 Million USD | 19.837% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 6.156% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 68.557% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.959% |
| Sintx Technologies, Inc. | 4.24 Million USD | 77.849% |
| Quanterix Corporation | 41.46 Million USD | 97.732% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 59.952% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -20.091% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.899% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.818% |
| ReWalk Robotics Ltd. | 1.9 Million USD | 50.588% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -290.373% |
| Hyperfine, Inc. | 185 Thousand USD | -408.279% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 99.511% |
| Biomerica, Inc. | 785 Thousand USD | -19.785% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -109.199% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -154.067% |
| Silk Road Medical, Inc | 84.63 Million USD | 98.889% |